Issue 4/2017
Content (19 Articles)
CCAT1: an oncogenic long noncoding RNA in human cancers
Xiaoqiang Guo, Yuming Hua
Men and women show similar survival rates after breast cancer
Paulo Franscisco Mascarenhas Bender, Letícia Lima de Oliveira, Célia Regina Costa, Suzana Sales de Aguiar, Anke Bergmann, Luiz Claudio Santos Thuler
Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines
Julia Kneissl, Anja Hartmann, Nicole Pfarr, Franziska Erlmeier, Thomas Lorber, Simone Keller, Gwen Zwingenberger, Wilko Weichert, Birgit Luber
Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer
Weiwei Liang, Zhiwei Xie, Weiling Cui, Yan Guo, Lijuan Xu, Jueheng Wu, Hongyu Guan
Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients
Richard Ofner, Cathrin Ritter, Barbara Heidenreich, Rajiv Kumar, Selma Ugurel, David Schrama, Jürgen C. Becker
Identification of a prognostic 5-Gene expression signature for gastric cancer
Jun-Yi Hou, Yu-Gang Wang, Shi-Jie Ma, Bing-Yin Yang, Qian-Ping Li
A novel loss-of-function heterozygous BRCA2 c.8946_8947delAG mutation found in a Chinese woman with family history of breast cancer
Jing Ma, Jichun Yang, Wenjing Jian, Xianming Wang, Deyong Xiao, Wenjun Xia, Likuan Xiong, Duan Ma
Depletion of p42.3 gene inhibits proliferation and invasion in melanoma cells
Hui Liu, Min Zhu, Zhongwu Li, Yan Wang, Rui Xing, Youyong Lu, Weicheng Xue
Study of early stage non-small-cell lung cancer using Orbitrap-based global serum metabolomics
Agnieszka Klupczynska, Paweł Dereziński, Timothy J. Garrett, Vanessa Y. Rubio, Wojciech Dyszkiewicz, Mariusz Kasprzyk, Zenon J. Kokot
Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme
Jia-Bin Wang, Feng-Hua Liu, Jian-Hang Chen, Hai-Tao Ge, Lu-Yan Mu, Hong-Bo Bao, Zhi-Guo Lin
Current developments in cancer care: including the patients’ perspective—3rd European Roundtable Meeting (ERTM) June 17, 2016, Berlin, Germany
O. Ortmann, W. Rösler, U. Helbig, Josep M. Borras, Anke Bramesfeld, Johannes Bruns, Jan-Willem Coebergh, Francesco de Lorenzo, David H. -U. Haerry, Michael Hallek, Ulrike Helbig, Joan Kelly, Monika Klinkhammer-Schalke, Christoph Kowalski, Margarete Landenberger, Katrin Mugele, Alice Nennecke, Olaf Ortmann, Ulrik Ringborg, Wiebke Rösler, Hilde Schulte, Wendy Yared
Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization
Johannes Mischinger, Lutz Philipp Guttenberg, Jörg Hennenlotter, Georgios Gakis, Stefan Aufderklamm, Steffen Rausch, Eva Neumann, Jens Bedke, Stefan Kruck, Christian Schwentner, Arnulf Stenzl, Tilman Todenhöfer
Preoperative characteristics of the P.R.O.S.T.A.T.E. scores: a novel predictive tool for the risk of positive surgical margin after radical prostatectomy
Ben Xu, Cheng Luo, Qian Zhang, Jie Jin
Fingerprint changes among cancer patients treated with paclitaxel
Payam Azadeh, Simin Dashti-Khavidaki, Ali Yaghobi Joybari, Samaneh Sarbaz, Atefeh Jafari, Mehdi Yaseri, Afshin Amini, Maryam Farasatinasab
Prognostic impact of tumour burden measured by quantitative real-time PCR from sentinel lymph nodes of melanoma patients: data from 10-year follow-up
Thomas Kurt Eigentler, Joachim Hinderer, Seema Noor, Claus Garbe, Ulrike Leiter
Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation
Osamu Imataki, Kensuke Matsumoto, Makiko Uemura
A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors
Constantinos E. Alifieris, Kyriakos Orfanakos, Aristina Papanota, George P. Stathopoulos, Nikolaos Sitaras, Dimitrios T. Trafalis
Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up
Jian-Xian Lin, Qing-Feng Chen, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jia-Bin Wang, Jun Lu, Qi-Yue Chen, Long-Long Cao, Mi Lin, Ru-Hong Tu, Chang-Ming Huang
Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting
Thomas M. Atkinson, Lauren J. Rogak, Narre Heon, Sean J. Ryan, Mary Shaw, Liora P. Stark, Antonia V. Bennett, Ethan Basch, Yuelin Li